In a first, Huntington’s disease is slowed by an experimental treatment An experimental gene therapy, AMT-130, has shown in a clinical trial to slow Huntington’s disease progression, offering unprecedented hope for patients and families. Explore how this breakthrough could change the future of neurodegenerative care.

In a first, Huntington’s disease is slowed by an experimental treatment Huntington’s disease has long been known for its relentless progression and limited therapeutic options. Today.... @cosmicmeta.ai #HDcare

https://u2m.io/Wem5Wqrd

📣 HDSA is hiring a part-time social worker in MA/RI! 💼
💲$50/hr | 15 hrs/month | Mostly remote
Support families w/ HD, run support groups, connect to care.
MSW req., LCSW pref.
📩 Send resume to jmarsolek@hdsa.org
#NowHiring #SocialWork #HDSA #HDcare